Blast Phase Chronic Myeloid Leukemia: Clinical Trials

1 trial for Blast Phase Chronic Myeloid Leukemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1
Phase 21Recruiting 1

Follow Blast Phase Chronic Myeloid Leukemia: new trials by email Literature Review of Blast Phase Chronic Myeloid Leukemia trials Research Report on Blast Phase Chronic Myeloid Leukemia

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors
Ponatinib - Acute Myeloid Leukemia, Accelerated Phase Chronic Myeloid Leukemia
Phase 1 / Phase 2RecruitingIncyte Biosciences International Sàrl702020-01-292026-11-13

Narrower conditions

Blast Crisis (1)  ·  Leukemia (1)  ·  Leukemia, Myeloid, Accelerated Phase (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Leukemia, Myeloid, Chronic-Phase (1)  ·  Lymphoma (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)

Broader conditions

Bone Marrow Diseases (1)  ·  Carcinogenesis (1)  ·  Cell Transformation, Neoplastic (1)  ·  Chronic Disease (1)  ·  Disease Attributes (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Leukemia, Lymphoid (1)  ·  Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1)  ·  Leukemia, Myeloid (1)  ·  Lymphatic Diseases (1)  ·  Lymphoproliferative Disorders (1)  ·  Myeloproliferative Disorders (1)

Interventions

ponatinib (1)

Sponsors

Incyte Biosciences International Sàrl (1)

Countries

Belgium (1)  ·  France (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Spain (1)  ·  Sweden (1)  ·  United Kingdom (1)

Top investigators

Mohammed-El-Amine Bensmaine, MD (1)

NIH funding

2018 (1), 2023 (1)